According to the Huntington’s Disease News: “Final decision on ifezuntirgene inilparvovec expected by May 1 of next year”
See the full article here: https://huntingtonsdiseasenews.com/news/fda-grants-priority-review-gene-therapy-huntingtons/?utm_mc_euid=53a43c6774&utm_source=HUN&utm_campaign=f15d35a964-Email_ENL_US_HUN&utm_medium=email&utm_term=0_f42d6c3322-f15d35a964-71584185
